OBSERVATIONS IN DIAGNOSIS AND TREATMENT OF ORAL CANCER OVER THE PAST 45 YEARS Lessons remain in identifying malignant disorders and prevention across health settings
With
Professor Peter Thomson,
Head of Dentistry and Professor of Oral and Maxillofacial Sciences
James Cook University, Cairns
SEGMENT
Filmed in the Gold Coast | May 2026
Peter Thomson is Academic Head of Dentistry and Professor of Oral & Maxillofacial Sciences in the College of Medicine & Dentistry at James Cook University, Australia. A UK and Australian specialist in Oral & Maxillofacial Surgery and Oral Medicine, he qualified BDS from Manchester University and MBBS from Newcastle upon Tyne, gaining Fellowships in Dental Surgery from the Royal College of Surgeons of England, Ireland and Glasgow and a Fellowship in Surgery from Edinburgh, specializing in Head & Neck Oncology.
He completed MSc and PhD degrees in epithelial biology and cancer research at Manchester University, where he was Lecturer, before returning to Newcastle in 1996 as Professor of Oral & Maxillofacial Surgery. In 2009, he was appointed Hunterian Professor at the Royal College of Surgeons of England and in 2011 King James IV Professor at the Royal College of Surgeons in Edinburgh. In 2014, he gained a Manchester Higher Doctorate (DDSc) for oral oncology research, and in 2016 an MD from the University of Bath for his thesis on interventional management of potentially malignant disorders.
Developing an extensive international profile, Peter was appointed Visiting Professor at the National University of Singapore in 2014 before joining the University of Queensland’s School of Dentistry as Professor of Maxillofacial Surgery & Academic Clinical Director in 2016. He was recruited to The University of Hong Kong in October 2017 to become Associate Dean at the Faculty of Dentistry and Director of the Prince Philip Dental Hospital. He has also held Academic Head and Dean of Dentistry positions at the University of Central Lancashire, UK and Griffith University in Australia. He was invited to join James Cook University as Head of Dentistry in 2021.
Author of more than 350 research papers and 2 oral cancer textbooks, Peter is an internationally recognised authority in oncology, population health and dental education. His research emphasis encompasses oral carcinogenesis, epithelial cell biology, and the early diagnosis and interventional management of cancer.
Source: James Cook University website
Media access credit: Oral Health Association of Australia (OHAA)
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
-
Early detection & surveillance guides for pancreatic cancer
Pancreatic cancer remains one of Australia’s deadliest cancers, with five-year survival rates hovering at just 14%, with little improvement over several decades. Often called the ‘silent killer’, the disease frequently presents with minimal or vague symptoms, resulting in late diagnoses and poor outcomes. Pancare Foundation is leading the rollout of new clinical resources and surveillance guides to support healthcare professionals in identifying at-risk patients and promoting early detection.
-
Landmark Australian-led study revises thresholds to diagnose and treat anaemia
In 2014, WEHI researchers began a study at the request of the World Health Organization (WHO), to formally review its global anaemia guidelines that were last updated in 1968.
Study lead and Acting WEHI Deputy Director, Professor Sant-Rayn Pasricha, speaking to Australian Health Journal said while anaemia can be diagnosed by measuring the amount of haemoglobin in the blood, there is currently no consensus on the thresholds that should be used to define the condition.
